Table 3.
Differential lipids identified by Pseudotargeted Lipidomics.
| Group | Metabolite | VIP | P-value | FC | Class | Ion mode | KEGG |
|---|---|---|---|---|---|---|---|
| DAG (18:1/18:2) | 8.29 | 0.0061 | 2.34 | Glycerolipids | pos | – | |
| DAG (18:2/18:2) | 6.39 | 0.0100 | 2.37 | Glycerolipids | pos | C00165 | |
| BSS vs HC | FA (18:2) | 5.08 | 0.0290 | 1.48 | Fatty acyls | neg | – |
| TAG52:4(16:0) | 5.08 | 0.027 | 1.59 | Glycerolipids | Pos | – | |
| FA(20:1) | 1.46 | 0.01 | 1.23 | Fatty acyls | neg | – | |
| DAG (18:1/18:2) | 6.34 | 0.0001 | 1.86 | Glycerolipids | pos | – | |
| TAG52:3(16:0) | 5.35 | 0.0054 | 1.48 | Glycerolipids | pos | – | |
| nBSS vs HC | TAG52:4(16:0) | 5.08 | 0.0058 | 1.55 | Glycerolipids | pos | – |
| DAG (18:1/18:1) | 4.90 | 0.007 | 2.36 | Glycerolipids | pos | – | |
| TAG50:2(16:0) | 4.69 | 0.039 | 1.87 | Glycerolipids | pos | – | |
| PC (18:2/18:2) | 6.85 | 0.0468 | 1.73 | Glycerophospholipids | neg | C00157 | |
| TAG52:4(20:4) | 1.45 | 0.0355 | 0.39 | Glycerolipids | pos | – | |
| BSS vs nBSS | CE (16:1) | 1.35 | 0.0401 | 0.32 | Sterol Lipids | pos | – |
| PI (16:0/18:2) | 1.34 | 0.0453 | 1.43 | Glycerophospholipids | neg | C00626 | |
| PC (18:2/18:3) | 1.34 | 0.0024 | 3.17 | Glycerophospholipids | neg | C00157 |
BSS, blood-stasis syndrome; nBSS, non-blood-stasis syndrome; HC, healthy control.